• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; TOTAL PROSTATE SPECIFIC ANTIGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; TOTAL PROSTATE SPECIFIC ANTIGEN Back to Search Results
Catalog Number 08791686190
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/14/2022
Event Type  malfunction  
Event Description
The initial reporter received questionable elecsys total psa immunoassay results from 3 patients on a cobas 6000 e601 module.On (b)(6) 2022, patient (b)(6) had a total psa result of 0.027 ng/ml and a free psa result of 0.043 ng/ml.On (b)(6) 2022, patient (b)(6) had a total psa result of 0.006 ng/ml with flag and a free psa result of 0.037 ng/ml.On (b)(6) 2022, patient (b)(6) had a total psa result of 0.017 ng/ml and a free psa result of 0.039 ng/ml.On (b)(6) 2022, patient (b)(6) had another sample collected and the total psa result was 0.024 ng/ml and a free psa result of 0.042 ng/ml.On (b)(6) 2022 at 1:19 p.M., patient (b)(6) had another sample collected.The total psa result was 0.006 ng/ml with flag and the free psa result was 0.038 ng/ml.At 9:20 p.M., the patient had an additional total psa result of 0.006 ng/ml with flag and a free psa result of 0.037 ng/ml.No questionable results were reported outside of the laboratory.The analyzer serial number is (b)(4).This medwatch will cover total psa.Refer to medwatch with patient identifier (b)(6) for information on the free psa results.
 
Manufacturer Narrative
The investigation found that the customer's calibration signals for free psa calibrator level 1 were below the expected range.It was also found that there were several maintenance activities that were overdue.The investigation is ongoing.
 
Manufacturer Narrative
The investigation determined that per product labeling, prostatectomized patient measurement of total psa is not covered by the intended use.Per product labeling, "this assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate-specific antigen (tpsa) in human serum and plasma, is indicated for the measurement of total psa in conjunction with digital rectal examination (dre) as an aid in the detection of prostate cancer in men aged 50 years or older." additionally, free psa product labeling states, "this assay is indicated for measurement of fpsa in conjunction with the elecsys total psa assay to develop a ratio (% fpsa) of fpsa to tpsa.This ratio is useful when used in conjunction with the elecsys total psa test as an aid in distinguishing prostate cancer from benign prostatic conditions in men age 50 years or older who have a digital rectal examination (dre) that is not suspicious for prostate cancer and an elecsys total psa value in the range 4 ng/ml to 10 ng/m." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA
Type of Device
TOTAL PROSTATE SPECIFIC ANTIGEN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15608448
MDR Text Key306912288
Report Number1823260-2022-03171
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Catalogue Number08791686190
Device Lot Number61494901
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age72 YR
Patient SexMale
-
-